Skip to main content
Journal cover image

INTRA-TARGET MICRODOSING (ITM), A NOVEL DRUG DEVELOPMENT APPROACH: PROOF-OF-CONCEPT IN HUMANS

Publication ,  Conference
Burt, T; MacLeod, DB; Kihak, L; Hawk, T; Turkington, T; Santoro, A; DeMasi, DK; Feinglos, M; Noveck, RJ; Rowland, M
Published in: CLINICAL PHARMACOLOGY & THERAPEUTICS
February 1, 2017

Duke Scholars

Published In

CLINICAL PHARMACOLOGY & THERAPEUTICS

EISSN

1532-6535

ISSN

0009-9236

Publication Date

February 1, 2017

Volume

101

Issue

S1

Start / End Page

S23 / S23

Location

Washington, DC

Publisher

WILEY-BLACKWELL

Conference Name

Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)

Related Subject Headings

  • Pharmacology & Pharmacy
  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Burt, T., MacLeod, D. B., Kihak, L., Hawk, T., Turkington, T., Santoro, A., … Rowland, M. (2017). INTRA-TARGET MICRODOSING (ITM), A NOVEL DRUG DEVELOPMENT APPROACH: PROOF-OF-CONCEPT IN HUMANS. In CLINICAL PHARMACOLOGY & THERAPEUTICS (Vol. 101, pp. S23–S23). Washington, DC: WILEY-BLACKWELL.
Burt, T., D. B. MacLeod, L. Kihak, T. Hawk, T. Turkington, A. Santoro, D. K. DeMasi, M. Feinglos, R. J. Noveck, and M. Rowland. “INTRA-TARGET MICRODOSING (ITM), A NOVEL DRUG DEVELOPMENT APPROACH: PROOF-OF-CONCEPT IN HUMANS.” In CLINICAL PHARMACOLOGY & THERAPEUTICS, 101:S23–S23. WILEY-BLACKWELL, 2017.
Burt T, MacLeod DB, Kihak L, Hawk T, Turkington T, Santoro A, et al. INTRA-TARGET MICRODOSING (ITM), A NOVEL DRUG DEVELOPMENT APPROACH: PROOF-OF-CONCEPT IN HUMANS. In: CLINICAL PHARMACOLOGY & THERAPEUTICS. WILEY-BLACKWELL; 2017. p. S23–S23.
Burt, T., et al. “INTRA-TARGET MICRODOSING (ITM), A NOVEL DRUG DEVELOPMENT APPROACH: PROOF-OF-CONCEPT IN HUMANS.” CLINICAL PHARMACOLOGY & THERAPEUTICS, vol. 101, no. S1, WILEY-BLACKWELL, 2017, pp. S23–S23.
Burt T, MacLeod DB, Kihak L, Hawk T, Turkington T, Santoro A, DeMasi DK, Feinglos M, Noveck RJ, Rowland M. INTRA-TARGET MICRODOSING (ITM), A NOVEL DRUG DEVELOPMENT APPROACH: PROOF-OF-CONCEPT IN HUMANS. CLINICAL PHARMACOLOGY & THERAPEUTICS. WILEY-BLACKWELL; 2017. p. S23–S23.
Journal cover image

Published In

CLINICAL PHARMACOLOGY & THERAPEUTICS

EISSN

1532-6535

ISSN

0009-9236

Publication Date

February 1, 2017

Volume

101

Issue

S1

Start / End Page

S23 / S23

Location

Washington, DC

Publisher

WILEY-BLACKWELL

Conference Name

Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT)

Related Subject Headings

  • Pharmacology & Pharmacy
  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences